Effects of difructose dianhydride (DFA)-IV on in vitro fertilization in pigs

Difructose dianhydride IV (DFA-IV) is produced from levan, which is a natural polysaccharide that belongs to thefructan family, through the activity of levan fructotransferase (LF) derived from microorganisms. Recently, DFA-IVhas been expected to have diverse applications in the food and medical ind...

Full description

Saved in:
Bibliographic Details
Published in生物医学研究杂志:英文版 Vol. 31; no. 5; pp. 453 - 461
Main Author Young-Joo Yi;S. Kamala-Kannan;Jeong-Muk Lim;Byung-Taek Oh;Sang-Myeong Lee
Format Journal Article
LanguageEnglish
Published 2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Difructose dianhydride IV (DFA-IV) is produced from levan, which is a natural polysaccharide that belongs to thefructan family, through the activity of levan fructotransferase (LF) derived from microorganisms. Recently, DFA-IVhas been expected to have diverse applications in the food and medical industry. Here, we examined the potentialapplication of DFA-IV for in vitro fertilization (IVF) in pigs. In the assessment of acrosomal integrity duringincubation, intact acrosomal or viable spermatozoa were highly sustained in 0.1% or 0.25% DFA-IV (69.8%-70.8%,P 〈 0.05). Reactive oxygen species (ROS) levels during sperm incubation decreased following the addition of DFA-IV, and 0.1%-0.5% DFA-IV in particular significantly decreased ROS production relative to that seen with no additionor 0.75% DFA-IV. Total fertilization (mono + polyspermic oocyte) rate was significantly higher in the addition of0.1% DFA-IV (94.2%) than with other concentrations (71.8%-86.7%, P 〈 0.05). When using reduced IVF times andlower sperm numbers, we found that addition of 0.1%-0.5% DFA-IV significantly increased the fertilization rate(P〈0.05). Fertilized oocytes treated with 0.1% DFA-IV exhibited higher embryonic development and blastocystformation than those treated with other concentrations (P 〈 0.05). Consequently, the addition of DFA-IV during IVFimproved fertilization and embryonic development, suggesting the possible use of novel sugars for enhancement ofassisted reproductive technology (ART) in mammals.
Bibliography:32-1810/R
ISSN:1674-8301